Javier F Torres-Roca
Overview
Explore the profile of Javier F Torres-Roca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1742
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berglund A, Puskas J, Yoder S, Smith A, Marchion D, Qin D, et al.
Cancer Res Commun
. 2025 Feb;
5(3):389-397.
PMID: 39932296
The RSI and 12CK GES are two GESs that predict tumor radiation sensitivity or the presence of tertiary lymphoid structures in tumors, respectively. These GESs were assessed within the CLIA...
2.
Niraula D, Cuneo K, Dinov I, Gonzalez B, Jamaluddin J, Jin J, et al.
Nat Commun
. 2025 Jan;
16(1):1138.
PMID: 39881134
AI decision support systems can assist clinicians in planning adaptive treatment strategies that can dynamically react to individuals' cancer progression for effective personalized care. However, AI's imperfections can lead to...
3.
Liveringhouse C, Sim A, Zhang J, Jain R, Naidu S, Linkowski L, et al.
Clin Genitourin Cancer
. 2024 Oct;
22(6):102222.
PMID: 39353214
Background: Neuroendocrine carcinoma of the bladder (NEC-bladder) is a rare disease with poor outcomes and variable treatment approaches. Materials And Methods: Patients with localized NEC-bladder treated with surgery or radiation...
4.
Berglund A, Puskas J, Yoder S, Smith A, Marchion D, Qian D, et al.
bioRxiv
. 2024 Sep;
PMID: 39345465
Background: The radiation sensitivity index (RSI) and 12-chemokine gene expression signature (12CK GES) are two gene expression signatures (GES) that were previously developed to predict tumor radiation sensitivity or identify...
5.
Hall W, Mathison A, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, et al.
Int J Radiat Oncol Biol Phys
. 2024 May;
120(2):570-578.
PMID: 38819340
Purpose: Changes in quantitative magnetic resonance imaging (qMRI) are frequently observed during chemotherapy or radiation therapy (RT). It is hypothesized that qMRI features are reflective of underlying tissue responses. It's...
6.
Niraula D, Cuneo K, Dinov I, Gonzalez B, Jamaluddin J, Jin J, et al.
medRxiv
. 2024 May;
PMID: 38746238
Background: Adaptive treatment strategies that can dynamically react to individual cancer progression can provide effective personalized care. Longitudinal multi-omics information, paired with an artificially intelligent clinical decision support system (AI-CDSS)...
7.
Chiang C, Chan K, Li H, Ng W, Chow J, Choi H, et al.
Radiother Oncol
. 2024 Apr;
196:110287.
PMID: 38636709
Background: Locally advanced nasopharyngeal cancer (NPC) patients undergoing radiotherapy are at risk of treatment failure, particularly locoregional recurrence. To optimize the individual radiation dose, we hypothesize that the genomic adjusted...
8.
Liveringhouse C, Netzley A, Bryant J, Linkowski L, Weygand J, Sandoval M, et al.
Adv Radiat Oncol
. 2023 Dec;
8(6):101268.
PMID: 38047218
Purpose: Bladder preservation with trimodal therapy (TMT; maximal tumor resection followed by chemoradiation) is an effective paradigm for select patients with muscle invasive bladder cancer. We report our institutional experience...
9.
Ho E, De Cecco L, Cavalieri S, Sedor G, Hoebers F, Brakenhoff R, et al.
medRxiv
. 2023 Sep;
PMID: 37745365
Background: Treatment decision-making in oropharyngeal squamous cell carcinoma (OPSCC) includes clinical stage, HPV status, and smoking history. Despite improvements in staging with separation of HPV-positive and -negative OPSCC in AJCC...
10.
Torres-Roca J, Grass G, Scott J, Eschrich S
Semin Radiat Oncol
. 2023 Jun;
33(3):221-231.
PMID: 37331777
The genomic era has significantly changed the practice of clinical oncology. The use of genomic-based molecular diagnostics including prognostic genomic signatures and new-generation sequencing has become routine for clinical decisions...